2-(nitrooxy)ethyl apovincaminate has been researched along with Breast Cancer in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Babilonia, MB; Bower, J; Cole, S; Culakova, E; Desta, Z; Han, HS; Heckler, C; Hoogland, AI; Janelsins, M; Jim, HSL; Morrow, G; Peppone, L; Williams, GC | 1 |
1 trial(s) available for 2-(nitrooxy)ethyl apovincaminate and Breast Cancer
Article | Year |
---|---|
A randomized placebo-controlled trial of bupropion for Cancer-related fatigue: Study design and procedures.
Topics: Age Factors; Antidepressive Agents, Second-Generation; Breast Neoplasms; Bupropion; Cancer Survivors; Cytochrome P-450 CYP2B6; Delayed-Action Preparations; Depression; Double-Blind Method; Fatigue; Female; Health Behavior; Humans; Menopause; Quality of Life; Research Design; Socioeconomic Factors; Vinca Alkaloids | 2020 |